Purchase Order 75N92C24P00026

Award Date 7/31/24
Potential Completion Date 8/31/24
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Hauppauge, NY 11788, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to Chem-Master International, Inc., a research, development, and manufacturing company, for the delivery of an Imidazoquinoline Compound 1 (1g). The contract has a ceiling value of $22,000.00 and a completion date of February 18, 2016. Chem-Master International has previously received other federal contract and grant awards from the Department...
This federal contract was awarded by the National Institutes of Health (NIH), which is a component of the Department of Health and Human Services (HHS), to MedChemExpress LLC, a New Jersey-based provider of biochemicals, bioactive compounds, and other life science research materials. The contract is for the custom synthesis of 30 grams of a single chemical intermediate, with a period of performance from July 2, 2021, to September 1, 2021. The award is a firm-fixed-price purchase order with a...
<p>The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm-fixed-price purchase order to Chemdiv, Inc. to provide 10,000 proprietary chemical compounds at 8 micromolar each. The total potential value of the award is $128,000.00. The award was not set aside for any specific business type. The contract has a completion date of September 4, 2017.</p>
The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $11,035 purchase order to Medchemexpress LLC of Princeton, New Jersey. The firm fixed price contract runs from August 23, 2023 through October 31, 2023 to procure unspecified products or services for the NIH. As a leading biomedical research agency, the NIH likely sought laboratory supplies or equipment from Medchemexpress to support its efforts advancing...
This is a $24,900.00 firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Chemogenics Biopharma, LLC, a for-profit limited liability company and sole proprietorship, on July 23, 2019. The contract has a completion date of September 30, 2019 and does not have a set-aside designation. Chemogenics Biopharma, LLC is a leading company in preclinical drug discovery and has been awarded several...
This is a $90,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is a civilian agency of the U.S. government. The contract, which does not have a set-aside designation, is for the &quot;SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)&quot; program and was awarded to DC Chemicals LIMITED, a for-profit limited liability company, on July 9, 2015. The period of performance for this contract ends on November 30, 2015.
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a Firm Fixed Price Purchase Order contract to Asischem Inc. to provide custom synthesis of a chemical compound. The contract, valued at $4,890.00, was awarded on August 3, 2015 with a completion date of December 1, 2015. This contract was not set aside for any specific business type or size. Based on the agency name, this contract is likely related to NIAID's research and development programs focused on infectious...
This is a $249,500 firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Chemogenics Biopharma, LLC, a small business. The contract is for synthesis and bioanalytical analysis support services related to the therapeutic areas of the microbiome, neurodegeneration, and addiction. The services will augment existing medicinal chemistry campaigns within the National Center for Advancing Translational...
This is a firm-fixed-price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Medical Science &amp; Computing, LLC. The contract was awarded under the Multiple Award Schedule (MAS) program administered by the General Services Administration (GSA). The contract is for a chemist to provide support for synthetic chemistry projects and composition production for the NHLBI Chemistry and Synthesis Center. The contract...
This is a $235,092.20 firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to MedChemExpress LLC, a New Jersey-based provider of biochemicals and other life science research materials. The contract is for the delivery of a custom chemical library of 84 items to the National Center for Advancing Translational Sciences (NCATS) to support its COVID-19 research. No set-aside designation was used. As a...

The federal contract award for $24,950.00 was granted to Chem-Master International, Inc. by the National Institute of Dental and Craniofacial Research, a civilian agency. The contract is for the production of compounds to support the development of a drug to treat inflammatory diseases. This is a firm fixed-price purchase order with an ultimate completion date of August 31, 2024. The contract does not have a set-aside designation. Chem-Master International is a for-profit organization and Subchapter S Corporation that specializes in custom synthesis, process development, and chemical research. The company has previously provided chemical compounds, kinase inhibitors, and other specialized molecules to the Department of Health and Human Services in support of the National Institutes of Health's research efforts.

Generated 8/1/24, 9:10 AM